Dear Chairman Leahy, Ranking Member Shelby, Chairwoman Murray, Ranking Member Blunt, Chairwoman DeLauro, and Ranking Member Cole:
“We write to support the research community’s FY 2022 NIH funding recommendation of at least $46.111 billion, a $3.177 billion increase over the comparable FY 2021 funding level for the NIH, which would allow for the NIH’s base budget to keep pace with the biomedical research and development price index (BRDPI) of 2.3 % and allow meaningful growth of 5%. We request a proportionate increase for the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) of at least $157 million for a total of $2.289 billion in FY 2022. This level of increase over its FY 2021 funding is necessary for NIDDK to fulfill its mission to conduct and support medical research, research training, and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases; along with population health research to improve people’s health and quality of life."
Read the Full Letter
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.